Milestone Pharmaceuticals, Inc. (MIST)
1.12
+0.08
(+7.69%)
USD |
NASDAQ |
Aug 25, 12:16
Milestone Pharmaceuticals EPS Diluted (Quarterly) : -0.2063 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2063 |
| March 31, 2026 | -0.2001 |
| December 31, 2025 | -0.1639 |
| September 30, 2025 | -0.1235 |
| June 30, 2025 | -0.1953 |
| March 31, 2025 | -0.3132 |
| December 31, 2024 | -0.2317 |
| September 30, 2024 | -0.1426 |
| June 30, 2024 | -0.1415 |
| March 31, 2024 | -0.2064 |
| December 31, 2023 | -0.4065 |
| September 30, 2023 | -0.3509 |
| June 30, 2023 | -0.3736 |
| March 31, 2023 | -0.3489 |
| December 31, 2022 | -0.308 |
| September 30, 2022 | -0.3426 |
| June 30, 2022 | -0.3938 |
| March 31, 2022 | -0.3316 |
| December 31, 2021 | -0.5647 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.4762 |
| June 30, 2021 | 0.02 |
| March 31, 2021 | -0.4193 |
| December 31, 2020 | -0.2905 |
| September 30, 2020 | -0.4023 |
| June 30, 2020 | -0.527 |
| March 31, 2020 | -0.6657 |
| December 31, 2019 | -0.7463 |
| September 30, 2019 | -0.5239 |
| June 30, 2019 | -1.035 |
| March 31, 2019 | -0.442 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -0.7327 |
| NervGen Pharma Corp. | -0.2283 |
| Clearmind Medicine, Inc. | -6.781 |
| Lexaria Bioscience Corp. | -1.204 |
| Target Group, Inc. (Canada) | -0.0004 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.61M |
| Revenue (Quarterly) | 0.559M |
| Total Expenses (Quarterly) | 29.17M |
| Enterprise Value | 100.70M |
| Gross Profit Margin (Quarterly) | 84.08% |
| Profit Margin (Quarterly) | -5.12K% |
| Earnings Yield | -61.95% |
| Normalized Earnings Yield | -61.95 |